TBPH
NASDAQ
KY
Theravance Biopharma, Inc. - Ordinary Shares
$16.02
▲ +$0.18
(+1.14%)
Vol 509K
11
Quality Score
ok
Deep Check
2/5
ok
Rev ✓
NI ✓
>IPO ✗
Mkt Cap
$948.1M
P/E
32.3
ROE
14.7%
Margin
36.5%
D/E
13.84
Beta
0.14
52W
$8–$20
Wall Street Consensus
13 analysts · Apr 20263
Strong Buy
5
Buy
5
Hold
0
Sell
0
Strong Sell
61.5%
Buy Rating
Price Chart
Earnings
Beat rate: 20.0%
Next Report
May 06, 2026
EPS Estimate: $-0.15
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.15 | — | — |
| Dec 2025 | $1.24 | $0.21 | $-1.03 |
| Sep 2025 | $-0.13 | $0.07 | +$0.20 |
| Jun 2025 | $0.69 | $-0.54 | $-1.23 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 6.9% | 6.9% | 6.9% | 6.9% | 14.7% | 14.7% |
| P/E (TTM) | 42.32 | 51.98 | 55.73 | 56.66 | 31.83 | 32.31 |
| Net Margin | 209.3% | 16.9% | 16.9% | 16.9% | 36.5% | 36.5% |
| Gross Margin | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| D/E Ratio | 14.07 | 14.07 | 14.07 | 14.07 | 13.84 | 13.84 |
| Current Ratio | 6.70 | 6.70 | 6.70 | 6.70 | 9.48 | 9.48 |
Key Ratios
ROA (TTM)
7.6%
P/S (TTM)
11.80
P/B
2.6
EPS (TTM)
$0.56
CF/Share
$-0.98
Rev Growth 3Y
+5.2%
52W High
$20.33
52W Low
$7.90
$7.90
52-Week Range
$20.33
How does TBPH compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
TBPH valuation vs Pharmaceuticals peers
P/E ratio
32.3
▲
44%
above
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
11.8
▲
138%
above
peers
(5.0)
vs Peers
vs Industry
Pricier
P/B ratio
2.6
▲
24%
above
peers
(2.1)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
TBPH profitability vs Pharmaceuticals peers
ROE
14.7%
▲
127%
above
peers
(-54.3%)
vs Peers
vs Industry
Top tier
Net margin
36.5%
▲
177%
above
peers
(-47.4%)
vs Peers
vs Industry
Below avg
Gross margin
100.0%
▲
46%
above
peers
(68.3%)
vs Peers
vs Industry
Below avg
ROA
7.6%
▲
120%
above
peers
(-37.4%)
vs Peers
vs Industry
Top tier
TBPH financial health vs Pharmaceuticals peers
D/E ratio
13.8
▲
799%
above
peers
(1.5)
vs Peers
vs Industry
Above avg
Current ratio
9.5
▲
182%
above
peers
(3.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.1
▼
85%
below
peers
(0.9)
vs Peers
vs Industry
More volatile
TBPH fundamentals radar
TBPH
Peer median
Industry
TBPH profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
TBPH vs peers: key metrics
Latest News
No related news yet